Diageo’s valuation is cheap, but the inflection point for growth and margins remains unclear; Goldman Sachs maintains a Neutral rating
AI summary card
Diageo’s valuation is cheap, but the inflection point for growth and margins remains unclear; Goldman Sachs maintains a Neutral rating
Goldman Sachs believes Diageo’s upcoming FY26 results will likely be broadly in line with guidance, but investors are primarily focused on the new management team’s strategic update, the pace of recovery in the US market, the effectiveness of the RTD relaunch and whether FY27 margins need to be reset.
- The 12-month target price is 1,800p, with an ADR target price of $96.00, implying approximately 15% upside.
- Goldman Sachs forecasts FY26 organic sales growth of -2.2% and organic EBIT growth of -0.2%, broadly in line with company guidance.
- The key FY27 debate concerns margins: price reinvestment, RTD investment and growth in lower-margin regions such as India and Africa could reduce group margins to approximately 28%.
- North America remains the largest variable, contributing approximately 40% of group sales and 50% of EBIT, but US spirits demand and premiumization trends remain weak.
- Guinness has been a recent highlight, but growth in the UK may slow, while expansion in continental Europe requires category development and follows a more complex path.
Report interpretation
Overview
This report examines Diageo’s dilemma between sales growth and margins. Goldman Sachs expects the company to report FY26 results and issue a strategic update on August 6. FY26 organic sales and EBIT performance are expected to be broadly in line with guidance, but the more important issues are FY27 guidance, the recovery path for the US business, the extent of pricing adjustments, the RTD strategy and the cost-savings plan. The report argues that Diageo’s valuation is already low, but the market has yet to reward its industry-leading margins because revenue growth visibility remains limited.
Core views
Goldman Sachs’ core views are: first, Diageo is unlikely to provide a reliable timetable for a recovery in US volumes in the near term, as the US spirits market has remained weak and the company continues to face share losses and an RTD lag; second, management may attempt to revive growth through price reductions, lower-priced new-brand offerings and greater RTD investment, but this would dilute FY27 margins; third, growth in emerging markets, Africa, Turkey and Guinness will not be sufficient to fully offset pressure from the US and China; fourth, a 50% dividend cut, asset disposals and free cash flow continue to support deleveraging.
Analysis framework
The report assesses Diageo’s growth recovery, margin reset and target price using company earnings forecasts, regional and category breakdowns, Nielsen data, US wholesaler surveys, expert interviews, a price-sensitivity model, peer margin and valuation comparisons, as well as DCF and P/E multiple valuation.
Methodology notes
50% DCF and 50% multiple-based valuation blend
The target price applies equal 50% weights to the DCF and multiple-based methods; the DCF assumes a 9.2% WACC and 2.5% perpetual growth rate, while the multiple-based method applies a 16x P/E to Q5-Q8 EPS forecasts.
Sensitivity of volume and EBIT margins to price reductions
Goldman Sachs estimates that a roughly 5% price cut for bottled spirits, equivalent to an approximately 3% group-wide price reduction, could dilute EBIT margins by around 130 basis points in the base case; more aggressive price reinvestment of approximately 10% could result in margin contraction of up to around 380 basis points.
Validation of off-premise sales, price mix and premiumization trends
The report uses Nielsen data from the US and Europe, DISCUS data and a US wholesaler survey to validate its conclusions that Diageo’s brand price mix has weakened, US premiumization has paused and RTD share is lagging.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- Diageo (DGE.L)Core covered asset
- Strengths
- Industry-leading EBIT margins, strong Guinness brand performance, free cash flow that continues to support deleveraging, and an attractive valuation of approximately 13x CY27 P/E.
- Weaknesses
- Weakness in the US and Chinese markets, pressure on US spirits share, lagging RTD share, and potential FY27 margin dilution from price reinvestment and regional mix.
- Comparison
- Diageo’s margins are higher than those of GS Distillers and GS Staples, but the company still trades at a discount to the consumer staples sector, indicating that the market is more focused on the revenue growth shortfall.
- Risks
- US volume recovery later than expected, failure to catch up in RTD, price cuts failing to stimulate sufficient volumes, slower Guinness growth and lower-than-expected cost savings.
- GuinnessKey growth brand
- Strengths
- Has consistently outperformed group organic sales growth since FY22, with strong performance in the UK, Ireland and US, as well as notable brand strength and expansion of consumption occasions.
- Weaknesses
- Growth may naturally slow as the UK comparison base expands, competition from Murphy’s and others is emerging, and continental European expansion requires development of the stout category.
- Comparison
- Compared with the UK and Ireland, stout category penetration is lower in continental Europe, making expansion more difficult.
- Risks
- Intensifying competition in the UK, widening price gaps and higher-than-expected category-building costs in continental Europe.
- North America segmentLargest profit variable
- Strengths
- Remains Diageo’s most important profit pool, with the report forecasting North America EBIT margins of approximately 34.4% in FY27.
- Weaknesses
- Weak US spirits demand, pressure on Tequila, negative price mix for brands such as Casamigos, and an RTD lag behind competitors including ABInBev and Sazerac.
- Comparison
- North America contributes approximately 40% of group sales and 50% of EBIT, so marginal changes there have a greater impact on group valuation than changes in other regions.
- Risks
- Price cuts causing margin contraction without a corresponding recovery in volumes, and continued stagnation in premiumization.
Key data
- 12-month target price1,800p / ADR $96.00The ADR target price was reduced from $97 to $96, primarily due to foreign-exchange effects.
- Current price1,564.5p / ADR $82.84Price disclosed on the report cover.
- Expected upside15.1% / ADR 15.9%Based on ordinary shares and ADRs, respectively.
- FY26 organic sales growth forecast-2.2%Goldman Sachs expects group organic sales to decline in FY26.
- FY26 organic EBIT growth forecast-0.2%Goldman Sachs expects FY26 organic EBIT to be broadly flat.
- FY27 group organic sales growth forecast+0.4%Growth is expected to be driven mainly by Europe, Africa and LAC, while North America remains a drag.
- FY27 group EBIT margin forecastApproximately 28% / 27.8%Price reinvestment, RTD and regional mix are the main pressures.
- Importance of North AmericaApproximately 40% of sales and 50% of EBITThe report emphasizes that North America is critical to Diageo’s valuation and earnings recovery.
- FY27 cost-savings assumption$300mApproximately $150m represents new initiatives beyond the existing $625m Accelerate plan.
- FY26 / FY27 free cash flow forecast$3.0bn / $2.8bnFY27 is slightly lower due to growth investment needs, but the dividend reduction and asset disposals should support deleveraging.
Impact & implications
For investors, Diageo’s rerating depends not on its current high margins in isolation, but on whether management can exchange a controlled margin reset for sustainable revenue growth. If US spirits volumes recover, RTD share improves and cost savings are sufficient to offset pricing pressure, the low valuation could unlock upside; if price reinvestment fails to drive volumes, FY27 margins and free cash flow could remain under pressure.
Risks
- Weakness in the US spirits market persists longer than expected, leaving Diageo unable to provide a clear timetable for a recovery in volume growth.
- Insufficient volume elasticity from price reinvestment and lower-priced new products causes margins to decline without a meaningful improvement in revenue.
- RTD investment dilutes margins, while Diageo fails to regain share from competitors such as ABInBev and Sazerac.
- Guinness growth slows in the UK and Ireland, while continental European expansion requires higher investment and faces category education challenges.
- A rising contribution from lower-margin regions such as India and Africa, combined with weakness in the US and China, creates a negative regional mix.
- The cost-savings plan falls short of expectations and fails to offset margin pressure from price reductions, A&P investment and product mix changes.
- Foreign exchange and the timing of asset disposals affect free cash flow, net debt and the ADR target price.
What to watch
- FY26 results and Sir Dave Lewis’s strategic update on August 6.
- FY27 sales growth and margin guidance, particularly whether the medium-term growth framework is formally reset.
- Changes in US spirits volumes, share and price mix, especially for Casamigos, Don Julio and the Tequila category.
- RTD strategic investment, distribution capabilities and progress in regaining share.
- The sustainability of Guinness growth in the UK, Ireland, US and continental Europe.
- The scale and execution pace of incremental cost savings, and whether they exceed the existing $625m Accelerate plan.
- The contribution of the EABL stake sale and the disposal of the Royal Challengers Bengaluru Cricket Team to deleveraging.